SCHEMBL20201102

SCHEMBL20201102

CN1CCCCCC12CCC2

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.48
SOS2 Q07890 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8732771 0.97 SOS1 (0.50) SOS1SOS2
SCHEMBL14962058 0.97 SOS1 (0.50) SOS1SOS2
SCHEMBL19199755 0.97 SOS1 (0.50) SOS1SOS2
SCHEMBL19199026 0.94 SOS1 (0.48) SOS1SOS2
SCHEMBL14962059 0.94 SOS1 (0.52) SOS1SOS2
SCHEMBL14962052 0.92 SOS1 (0.50) SOS1SOS2
SCHEMBL9965969 0.92
SCHEMBL14962054 0.88
SCHEMBL14962053 0.88 SOS1 (0.52) SOS1SOS2
SCHEMBL24081996 0.86 SOS1 (0.50) SOS1SOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES C1R, C9, C1S SOS1 3861/4885SOS2 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.